IP Library › Granted Patent US 7,030,221
Granted Patent B2
US 7,030,221 · App. 10/151,003 · Granted Apr 18, 2006

AMPA-binding human GluR3 receptors

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,030,221
App. No.
10/151,003
Granted
Apr 18, 2006
Kind
B2
Abstract

Described herein are isolated polynucleotides which code for a family of AMPA-type human CNS receptors. The receptors are characterized structurally and the construction and use of cell lines expressing these receptors are disclosed.

Claims (5)

1. A human GluR3A receptor subunit or a human GluR3B receptor subunit, wherein the GluR3A receptor subunit and the GluR3B receptor subunit are in a form essentially free from other proteins of human origin.

2. The human GluR3A receptor subunit according to claim 1 .

3. The human GluR3B receptor subunit according to claim 1 .

4. An immunogenic fragment of a human GluR3B receptor subunit, wherein the immunogenic fragment is selected from the group consisting of residues 178–193, residues 479–522, residues 594–603, and residues 817–866.

5. An immunogenic fragment of a human GluR3A receptor subunit, wherein the immunogenic fragment is selected from the group consisting of residues 178–193, residues 479–522, residues 594–603 and residues 817–866.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2008
From: NPS ALLELIX CORP.
To: NPS PHARMACEUTICALS, INC.
Reel/Frame 021339/0977 →